Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Transbiotec, Inc. (IMLE)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Transbiotec, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Transbiotec, Inc. since 2005.
The reporting company's ticker symbol is IMLE. The reporting company's CIK number is 1425627.
The total value of stock buying since 2005 is $2,038,110.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-28||Lanphere Michael A. (V.P. of Legal Affairs)||Buy||26,607,175||.05||1,383,573|
|2019-08-28||Mishal Devadatt M (Director)||Buy||13,134,420||.00||52,537|
|2019-08-28||Bennington Charles Warren (CEO, President and Secretary)||Buy||14,000,000||.04||602,000|
Insider trading activities including stock purchases, stock sales, and option exercises of IMLE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Transbiotec, Inc. (symbol IMLE, CIK number 1425627) see the Securities and Exchange Commission (SEC) website.